TransCode Therapeutics Inc (RNAZ): Insights At A Glance

TransCode Therapeutics Inc (RNAZ) concluded trading on Thursday at a closing price of $0.28, with 14.91 million shares of worth about $4.17 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -60.71% during that period and on September 05, 2024 the price saw a […]

TransCode Therapeutics Inc (RNAZ) Outlook Starting To Look Brighter?

TransCode Therapeutics Inc (RNAZ) concluded trading on Thursday at a closing price of $0.68, with 3.53 million shares of worth about $2.4 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -99.16% during that period and on Thursday, February 01 price saw a loss […]

Are Analysts Expecting A Better 2020 For TransCode Therapeutics Inc (RNAZ)?

Sabby Management LLC has recently announced that it has increased stake in TransCode Therapeutics Inc (NASDAQ:RNAZ) by 32.83%. After grabbing 0.25 million shares, the institutional investor is now in possession of 61872.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 1.25% having worth around $92614.0. Moreover, UBS Securities […]